Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13274 | 784 | 47.7 | 95% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TAK1 | Author keyword | 32 | 40% | 8% | 64 |
| 2 | TRAF4 | Author keyword | 23 | 76% | 2% | 16 |
| 3 | TRAF5 | Author keyword | 15 | 88% | 1% | 7 |
| 4 | TRAF2 | Author keyword | 13 | 33% | 4% | 33 |
| 5 | TGF BETA ACTIVATED KINASE 1 | Author keyword | 12 | 86% | 1% | 6 |
| 6 | TRAF6 | Author keyword | 10 | 23% | 5% | 39 |
| 7 | TRAF | Author keyword | 10 | 29% | 4% | 28 |
| 8 | TAB1 | Author keyword | 7 | 48% | 1% | 11 |
| 9 | TIFA | Author keyword | 6 | 80% | 1% | 4 |
| 10 | TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR | Author keyword | 5 | 60% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TAK1 | 32 | 40% | 8% | 64 | Search TAK1 | Search TAK1 |
| 2 | TRAF4 | 23 | 76% | 2% | 16 | Search TRAF4 | Search TRAF4 |
| 3 | TRAF5 | 15 | 88% | 1% | 7 | Search TRAF5 | Search TRAF5 |
| 4 | TRAF2 | 13 | 33% | 4% | 33 | Search TRAF2 | Search TRAF2 |
| 5 | TGF BETA ACTIVATED KINASE 1 | 12 | 86% | 1% | 6 | Search TGF+BETA+ACTIVATED+KINASE+1 | Search TGF+BETA+ACTIVATED+KINASE+1 |
| 6 | TRAF6 | 10 | 23% | 5% | 39 | Search TRAF6 | Search TRAF6 |
| 7 | TRAF | 10 | 29% | 4% | 28 | Search TRAF | Search TRAF |
| 8 | TAB1 | 7 | 48% | 1% | 11 | Search TAB1 | Search TAB1 |
| 9 | TIFA | 6 | 80% | 1% | 4 | Search TIFA | Search TIFA |
| 10 | TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR | 5 | 60% | 1% | 6 | Search TUMOR+NECROSIS+FACTOR+RECEPTOR+ASSOCIATED+FACTOR | Search TUMOR+NECROSIS+FACTOR+RECEPTOR+ASSOCIATED+FACTOR |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TAB1 | 32 | 78% | 3% | 21 |
| 2 | ACTIVATED KINASE 1 | 21 | 75% | 2% | 15 |
| 3 | SIGNAL TRANSDUCING PROTEINS | 19 | 68% | 2% | 17 |
| 4 | TAK1 | 18 | 27% | 7% | 57 |
| 5 | IL 1 SIGNALING PATHWAY | 16 | 56% | 3% | 20 |
| 6 | KINASE TAK1 | 16 | 43% | 4% | 29 |
| 7 | TRAF6 | 14 | 30% | 5% | 40 |
| 8 | TRAF6 DEFICIENT MICE | 14 | 65% | 2% | 13 |
| 9 | DEFECTIVE INTERLEUKIN 1 | 11 | 23% | 5% | 42 |
| 10 | FACTOR TRAF 1 | 10 | 73% | 1% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Targeting of TAK1 in inflammatory disorders and cancer | 2012 | 71 | 90 | 59% |
| Cell type-specific function of TAK1 in innate immune signaling | 2013 | 18 | 102 | 58% |
| All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction | 2002 | 335 | 120 | 52% |
| Ubiquitin-mediated activation of TAK1 and IKK | 2007 | 185 | 123 | 32% |
| The Role of Ubiquitin in NF-kappa B Regulatory Pathways | 2009 | 238 | 145 | 23% |
| Expanding TRAF function: TRAF3 as a tri-faced immune regulator | 2011 | 79 | 91 | 33% |
| Ubiquitin signalling in the NF-kappa B pathway | 2005 | 665 | 77 | 22% |
| TRAF3, ubiquitination, and B-lymphocyte regulation | 2015 | 1 | 92 | 33% |
| TAK1 regulates hepatic cell survival and carcinogenesis | 2014 | 2 | 74 | 72% |
| TAK1, more than just innate immunity | 2012 | 23 | 69 | 54% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CNRSUPR 6520 | 2 | 67% | 0.3% | 2 |
| 2 | MED EDUC IL 2193B | 2 | 43% | 0.4% | 3 |
| 3 | BONE SOFT TUMOR | 1 | 50% | 0.3% | 2 |
| 4 | CELL BIOL GRP B | 1 | 100% | 0.3% | 2 |
| 5 | INTERDISCIPLINARY PROGRAM MOL CELLULAR BIO | 1 | 18% | 0.8% | 6 |
| 6 | CELLULAR MOL BIOLMINATO KU | 1 | 19% | 0.6% | 5 |
| 7 | MOL GENOM PHARM | 1 | 27% | 0.4% | 3 |
| 8 | BIOL SCI ENVIRONM MOL TOXICOL | 1 | 50% | 0.1% | 1 |
| 9 | BK21 BIOBC | 1 | 50% | 0.1% | 1 |
| 10 | BROOKDALE DEV CELL MOL BIOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000183203 | TIR DOMAIN//PELLINO//INNATE IMMUN INFLAMMAT |
| 2 | 0.0000168936 | A20//STRESS ASSOCIATED PROTEIN//ZINC FINGER PROTEIN A20 |
| 3 | 0.0000160843 | PHARMACEUT PROTE//PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TUMOR NECROSIS FACTOR RECEPTOR TNFR |
| 4 | 0.0000129860 | CD40//CD40 LIGAND//CD40L |
| 5 | 0.0000119569 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
| 6 | 0.0000109012 | SOLUBLE CD30//SCD30//CD30 |
| 7 | 0.0000107771 | I KAPPA B//IKK//C REL |
| 8 | 0.0000104595 | DSK2//UBIQUILIN 1//LUBAC |
| 9 | 0.0000093032 | TPL2//TPL 2//TPL2 KINASE |
| 10 | 0.0000091568 | BCL10//PKC THETA//CARMA3 |